Pneumonia induced by covid19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group:??Dinvl drug,260 mg each time, 4 times a day for 7 days. Made by Health Medicine Chemistry Company. Intervention 2: Control group: Routine tablets is given daily f
Sponsors
Health Medicine Chemistry Company
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients up18 years old hospitalized Patient with SpO2:85-89% on room air at admission (if correct with nasal O2 maximum 6 liter/min to SpO2>=90 ) Patients with SpO2: 90-93% and RR>=30 clinical compatible patients with positive RT-PCR test or consistent HRCT to covid19 pneumonia Sign the study participation form
Exclusion criteria
Exclusion criteria: Known sensitivity to plant compounds. Pregnant woman Lactating woman Patients with active peptic.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to clinical recovery. Timepoint: Control clinical signs daily until discharge from the hospital. Method of measurement: Fever control with thermometer, oxygen saturation control with pulsoximetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| 14 days readmission after discharge. Timepoint: Up to 14 days after discharge. Method of measurement: All patients will be given a contact number to notify them if they are hospitalized again. All patients will be monitored by phone weekly for up to 4 weeks after the first day they are admitted. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Hosseinpour
Health Medicine Chemistry Company
Outcome results
None listed